Avista Pharma Solutions, Inc. dba Cambrex
FDA inspection history in Longmont, Colorado, 2024
- 1
- Form 483
Every document, by year
- Form 483
2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2024One Form 483, at Longmont, Colorado.
Cited most
Across all Avista Pharma Solutions, Inc. dba Cambrex observations on file
- 21 CFR 211.160General requirements2
- 21 CFR 211.194Laboratory records1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.25Personnel qualifications1
The complete Avista Pharma Solutions, Inc. dba Cambrex file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Longmont, Colorado
One Form 483 · 2024 · 4 observations
Latest: Form 483, May 3, 2024 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-05-03 | 483 Form 483 | Longmont, Colorado | 4 | $99 |
Investigators on these documents
FEI number 3012316957 · most recent document May 3, 2024
About Avista Pharma Solutions, Inc. dba Cambrex
How many FDA Form 483s has Avista Pharma Solutions, Inc. dba Cambrex received?
FDA Intel has 1 Form 483 on file for Avista Pharma Solutions, Inc. dba Cambrex; the most recent is dated May 3, 2024.
When was Avista Pharma Solutions, Inc. dba Cambrex last inspected by FDA?
The most recent FDA inspection document on file for Avista Pharma Solutions, Inc. dba Cambrex is a Form 483 dated May 3, 2024, for the site in Longmont, Colorado.
What did FDA cite at Avista Pharma Solutions, Inc. dba Cambrex?
The regulations cited most in the observations on file for Avista Pharma Solutions, Inc. dba Cambrex are 21 CFR 211.160 (General requirements), 2 times; 21 CFR 211.194 (Laboratory records), 1 time; 21 CFR 211.22 (Responsibilities of quality control unit), 1 time.